DrHouse vs eMed: Comparing Two ED Telehealth Options

Choose DrHouse if your priority is speed and a single, self-contained ED evaluation. Its whole pitch is getting you in front of a U.S.-licensed clinician fast, on demand, with any resulting prescription sent electronically to a pharmacy you pick. If you mainly want to be evaluated, ask your questions, and get a decision in one sitting, that is the model DrHouse is designed for.

Choose eMed if you want ED handled as part of ongoing care rather than a one-time transaction, or if you value its proctored at-home testing and chronic-care infrastructure. eMed's strength is a longer treatment relationship, which can suit someone managing several health goals at once and who sees ED as one piece of a bigger picture.

Both are legitimate routes to a licensed clinician, and neither dispenses medication itself. The decision is mostly about tempo: a fast one-and-done visit versus care embedded in a continuing relationship.

DrHouse operates as on-demand virtual care. You request a visit, connect by video with a board-certified U.S. clinician, and if the clinician determines treatment is appropriate, a prescription is sent electronically to your pharmacy. For ED, that means the clinician evaluates your history, asks about cardiovascular health and current medications, and decides whether a PDE5 inhibitor or another approach is suitable. The convenience is the lack of scheduling friction: it is marketed as minutes, not days.

eMed is structured differently. It became widely known for proctored at-home testing, where a guide observes a test by video, and it has expanded into chronic-condition and weight-management programs. Within that framework, an ED evaluation is a clinical visit handled by a licensed provider, but the surrounding experience is oriented toward continuity. If you are someone who wants follow-up, monitoring, and a provider who knows your broader history, eMed's design leans that way.

One thing both share: the clinician, not the platform, makes the prescribing decision. The app is the front door; the licensed provider is the one who can write a prescription, and a pharmacy is what fills it.

ED is most commonly treated with PDE5 inhibitors. According to FDA prescribing information, sildenafil (the active ingredient in Viagra) and tadalafil (the active ingredient in Cialis) are approved to treat erectile dysfunction. These are prescription-only drugs in the United States, which is why a consultation with a licensed provider is required on either platform; you cannot legitimately obtain them without one.

The most important safety fact is the same regardless of which service you use. Per FDA labeling, PDE5 inhibitors are contraindicated in patients taking nitrates (such as nitroglycerin) because the combination can cause a dangerous drop in blood pressure. There are additional cautions for certain heart conditions and some interacting medications. This is exactly why the visit is a real clinical evaluation and not a formality: the clinician is screening for these issues. Treat any platform that implies you can skip that step as a red flag.

We did not test prescriptions on either platform and make no claim about what any individual clinician will or will not prescribe. That decision is theirs, based on your health.

The two services price care differently. DrHouse emphasizes a per-visit and/or membership structure for fast access to a clinician. eMed's pricing varies by the specific program or test involved. Because both adjust pricing over time and bundle services in different ways, we are not publishing a single ED-visit dollar figure for either: we could not independently verify exact, current ED-visit prices, and quoting a stale number would be worse than none.

What we can say plainly: both are generally oriented toward cash-pay convenience rather than billing insurance for an ED visit, though policies differ and change. Before you commit on either platform, confirm the total cost of the visit, whether any membership is required, and what (if anything) the medication itself will cost at your pharmacy. The medication price is separate from the visit price and depends on the drug, dose, quantity, and your pharmacy, not on the telehealth service.

All pricing here is provider-attributed and should be verified at the source. Compounded medications, if ever offered, are not FDA-approved products; ask directly whether what you are being prescribed is an FDA-approved drug or a compounded preparation.

You want it handled today. If your goal is a quick evaluation and a decision in one sitting, DrHouse's on-demand model is the closer match. The advertised minutes-to-visit experience is the entire point of the product.

You want continuity. If you would rather a provider track your care over time, or you are already interested in eMed's testing or chronic-care programs, folding ED into that relationship can be more coherent than spinning up a separate one-off visit elsewhere.

You have cardiovascular risk factors or take other medications. Either way, expect a thorough screening. ED can be an early signal of cardiovascular issues, and the clinician should ask. Use the visit to surface your full medication list and heart history honestly so the provider can evaluate safely.

You want the lowest total cost. Compare the visit price plus the pharmacy price on both, and check whether a membership changes the math. Do not assume the cheaper visit yields the cheaper total.

It helps to place both against the more familiar ED-first brands. Services like Hims, BlueChew, Roman (Ro), Rex MD, and Lemonaid Health are built specifically around ED and men's health, with subscription flows designed to move you from intake to a recurring medication shipment. DrHouse and eMed are different animals: general telehealth platforms where ED is one of many things a clinician can evaluate. If you specifically want a streamlined ED subscription with chewables or branded packaging, the ED-first brands are engineered for that. If you want a general clinician visit, fast (DrHouse) or continuous (eMed), these two fit better.

None of this changes the underlying clinical reality. Across every one of these services, a licensed provider must evaluate you, the same PDE5-inhibitor safety rules apply, and the medication is filled by a pharmacy. The differences are in convenience, continuity, and packaging, not in the rules of prescribing.

In the interest of honesty, here is the boundary of our confidence.

What we could verify: that DrHouse positions itself as on-demand virtual care with U.S.-licensed clinicians and e-prescribing to a pharmacy of the patient's choice; that eMed is a telehealth practice known for proctored at-home testing and chronic/weight-management care; and the FDA-attributable drug facts about sildenafil and tadalafil, including the nitrate contraindication, which come from FDA prescribing information rather than either company.

What we could not independently verify and you should confirm at the source: exact, current ED-visit prices on either platform; whether either currently treats ED for your specific situation; precise visit-to-prescription timing in real cases; state-by-state clinician availability; and current insurance handling. These vary, change, and depend on your circumstances. Verify them directly with DrHouse and eMed before relying on anything here.

We did not receive payment from either company for this comparison, and placement on this site is never for sale.